ArticleJournal of immunology research2022

NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer.

Menglong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.